Concepedia

Meredith Hackel

MH

6

Publications

287

Citations

6

H-Index

2013

Active since

Affiliations

AstraZeneca (United States)(Current)

Meredith Hackel is an author at AstraZeneca (United States) specializing in antibiotics, antimicrobial resistance, and clinical microbiology.

Top concepts

Publications per year

2013–2021

6

Publications

6

Serotype prevalence and antibiotic resistance in Streptococcus pneumoniae clinical isolates among global populations

Meredith Hackel, Christine Lascols, S. Bouchillon et al. · Vaccine · 2013 · 120 citations

, , +10

Potent LpxC Inhibitors with <i>In Vitro</i> Activity against Multidrug-Resistant Pseudomonas aeruginosa

Kevin M. Krause, Cat M. Haglund, Christy M. Hebner et al. · Antimicrobial Agents and Chemotherapy · 2019 · 59 citations · Full text

Comparative Analysis of the Antibacterial Activity of a Novel Peptide Deformylase Inhibitor, GSK1322322

Karen O’Dwyer, Meredith Hackel, Sarah Hightower et al. · Antimicrobial Agents and Chemotherapy · 2013 · 38 citations · Full text

In vitro activity of Ceftaroline against bacterial pathogens isolated from patients with skin and soft tissue and respiratory tract infections in African and Middle Eastern countries: AWARE global surveillance program 2012–2014

James A. Karlowsky, Douglas J. Biedenbach, Samuel K. Bouchillon et al. · Diagnostic Microbiology and Infectious Disease · 2016 · 28 citations

, , +8

<i>In Vitro</i> Activity of AZD0914, a Novel Bacterial DNA Gyrase/Topoisomerase IV Inhibitor, against Clinically Relevant Gram-Positive and Fastidious Gram-Negative Pathogens

Douglas J. Biedenbach, Michael D. Huband, Meredith Hackel et al. · Antimicrobial Agents and Chemotherapy · 2015 · 24 citations · Full text

Rows per page

1–5 of 6